|
1
|
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes.
|
Nature
|
2010
|
14.50
|
|
2
|
Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature.
|
Am J Surg Pathol
|
2008
|
1.70
|
|
3
|
Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma.
|
Carcinogenesis
|
2005
|
1.59
|
|
4
|
Identification of a lysosomal pathway that modulates glucocorticoid signaling and the inflammatory response.
|
Sci Signal
|
2011
|
1.58
|
|
5
|
Somatic pairing of chromosome 19 in renal oncocytoma is associated with deregulated EGLN2-mediated [corrected] oxygen-sensing response.
|
PLoS Genet
|
2008
|
1.20
|
|
6
|
Activation of the PI3K/AKT pathway induces urothelial carcinoma of the renal pelvis: identification in human tumors and confirmation in animal models.
|
Cancer Res
|
2009
|
1.15
|
|
7
|
Comparison of array-based comparative genomic hybridization with gene expression-based regional expression biases to identify genetic abnormalities in hepatocellular carcinoma.
|
BMC Genomics
|
2005
|
1.14
|
|
8
|
Birt-Hogg-Dubé renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression.
|
BMC Med Genomics
|
2010
|
1.06
|
|
9
|
Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas.
|
Proc Natl Acad Sci U S A
|
2011
|
1.05
|
|
10
|
MK-STYX, a catalytically inactive phosphatase regulating mitochondrially dependent apoptosis.
|
Mol Cell Biol
|
2011
|
0.86
|
|
11
|
MEK2 is sufficient but not necessary for proliferation and anchorage-independent growth of SK-MEL-28 melanoma cells.
|
PLoS One
|
2011
|
0.84
|
|
12
|
Pharmacologic inhibition of MEK signaling prevents growth of canine hemangiosarcoma.
|
Mol Cancer Ther
|
2013
|
0.83
|
|
13
|
Cancer-type regulation of MIG-6 expression by inhibitors of methylation and histone deacetylation.
|
PLoS One
|
2012
|
0.79
|